Heart Test Laboratories, Inc. - Form 8-K Summary
Business Context and Reporting Period
Heart Test Laboratories, Inc. (HSCS) filed this Current Report on Form 8-K on September 6, 2024. The company is incorporated in Texas and its securities trade on The Nasdaq Stock Market LLC. The filing reports the entry into a material definitive agreement regarding a new debt financing arrangement.
Key Financial Metrics
- Debt Instrument: Unsecured promissory note (Streeterville Note) with a face value of $2,510,000.
- Net Proceeds: $1,860,000 received in cash.
- Interest Rate: 8.5% per annum.
- Maturity: 18 months from issuance (September 6, 2024).
- Original Issue Discount (OID): $500,000 included in the face value.
- Transaction Expenses: $10,000 reimbursed to the lender.
- Placement Agent Fees: 7% of gross cash proceeds paid to Maxim Group LLC and Ascendiant Capital Markets, LLC.
Material Changes and Terms
The company entered into a Note Purchase Agreement with Streeterville Capital, LLC. Key terms include:
- Redemption Rights: The lender may redeem portions of the note starting six months after issuance, capped at $270,000 per month.
- Repayment Covenant: If the outstanding balance is not reduced by at least $900,000 by the 12-month anniversary, the balance automatically increases by 5%.
- Default Penalties: Upon an event of default, the interest rate increases to the lesser of 18% or the maximum rate permitted by law, and the balance becomes immediately due.
- Prepayment: The company may prepay all or any portion of the note at any time.
Outlook, Risks, and Use of Proceeds
The company intends to use the net proceeds of $1,860,000 for general working capital purposes. The filing identifies customary events of default, including fundamental transactions such as mergers or changes in control without the lender's consent. The agreement includes indemnification provisions for the lender regarding breaches of representations or covenants.
Investor Verification Checklist
- Verify the company's ability to meet the $900,000 repayment threshold within 12 months to avoid the 5% balance penalty.
- Review the full text of the Note Purchase Agreement (Exhibit 10.1) and Promissory Note (Exhibit 10.2) for specific default triggers.
- Assess the impact of the 8.5% interest rate and potential 18% default rate on future cash flow and liquidity.
- Confirm the company's current cash position to ensure it can service the debt and fund operations with the $1.86 million in net proceeds.